Authors:
Kruger, P
Verheyden, S
Declerck, PJ
Engelborghs, Y
Citation: P. Kruger et al., Extending the capabilities of targeted molecular dynamics: Simulation of alarge conformational transition in plasminogen activator inhibitor 1, PROTEIN SCI, 10(4), 2001, pp. 798-808
Authors:
Bijnens, AP
Ngo, TH
Gils, A
Dewaele, J
Knockaert, I
Stassen, JM
Declerck, PJ
Citation: Ap. Bijnens et al., Elucidation of the binding regions of PAI-1 neutralizing antibodies using chimeric variants of human and rat PAI-1, THROMB HAEM, 85(5), 2001, pp. 866-874
Authors:
Seki, T
Miyasu, T
Noguchi, T
Hamasaki, A
Sasaki, R
Ozawa, Y
Okukita, K
Declerck, PJ
Ariga, T
Citation: T. Seki et al., Reciprocal regulation of tissue-type and urokinase-type plasminogen activators in the differentiation of murine preadipocyte line 3T3-L1 and the hormonal regulation of fibrinolytic factors in the mature adipocytes, J CELL PHYS, 189(1), 2001, pp. 72-78
Authors:
Bijnens, AP
Gils, A
Stassen, JM
Komissarov, AA
Knockaert, I
Brouwers, E
Shore, JD
Declerck, PJ
Citation: Ap. Bijnens et al., The distal hinge of the reactive site loop and its proximity - A target tomodulate plasminogen activator inhibitor-1 activity, J BIOL CHEM, 276(48), 2001, pp. 44912-44918
Authors:
Ngo, TH
Hoylaerts, MF
Knockaert, I
Brouwers, E
Declerck, PJ
Citation: Th. Ngo et al., Identification of a target site in plasminogen activator inhibitor-1 that allows neutralization of its inhibitory properties concomitant with an allosteric up-regulation of its antiadhesive properties, J BIOL CHEM, 276(28), 2001, pp. 26243-26248
Authors:
Isogai, C
Laug, WE
Shimada, H
Declerck, PJ
Stins, MF
Durden, DL
Erdreich-Epstein, A
DeClerck, YA
Citation: C. Isogai et al., Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin, CANCER RES, 61(14), 2001, pp. 5587-5594
Authors:
Gils, A
Knockaert, I
Brouwers, E
Declerck, PJ
Citation: A. Gils et al., Glycosylation dependent conformational transitions in plasminogen activator inhihitor-1: evidence for the presence of two active conformations, FIBRINOL PR, 14(1), 2000, pp. 58-64
Authors:
Leng, HMJ
Brouwers, E
Knockaert, I
Declerck, PJ
Citation: Hmj. Leng et al., Immunoassays for the quantitation of porcine PAI-1 antigen and activity inbiological fluid samples, THROMB HAEM, 84(6), 2000, pp. 1082-1086
Authors:
Vleugels, N
Leys, J
Knockaert, I
Declerck, PJ
Citation: N. Vleugels et al., Effect of stabilizing versus destabilizing interactions on plasminogen activator inhibitor-1, THROMB HAEM, 84(5), 2000, pp. 871-875
Authors:
Hellebrekers, BWJ
Trimbos-Kemper, GCM
Bakkum, EA
Trimbos, JBMZ
Declerck, PJ
Kooistra, T
Emeis, JJ
Citation: Bwj. Hellebrekers et al., Short-term effect of surgical trauma on rat peritoneal fibrinolytic activity and its role in adhesion formation, THROMB HAEM, 84(5), 2000, pp. 876-881
Authors:
Montes, R
Declerck, PJ
Calvo, A
Montes, M
Hermida, J
Munoz, MC
Rocha, E
Citation: R. Montes et al., Prevention of renal fibrin deposition in endotoxin-induced DIC through inhibition of PAI-1, THROMB HAEM, 84(1), 2000, pp. 65-70
Authors:
Cauwenberghs, N
Ajzenberg, N
Vauterin, S
Hoylaerts, MF
Declerck, PJ
Baruch, D
Deckmyn, H
Citation: N. Cauwenberghs et al., Characterization of murine anti-glycoprotein ib monoclonal antibodies thatdifferentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand Factor interaction, HAEMOSTASIS, 30(3), 2000, pp. 139-148
Authors:
Nar, H
Bauer, M
Stassen, JM
Lang, D
Gils, A
Declerck, PJ
Citation: H. Nar et al., Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation, J MOL BIOL, 297(3), 2000, pp. 683-695
Authors:
Bijnens, AP
Gils, A
Knockaert, I
Stassen, JM
Declerck, PJ
Citation: Ap. Bijnens et al., Importance of the hinge region between alpha-helix F and the main part of serpins, based upon identification of the epitope of plasminogen activator inhibitor type 1 neutralizing antibodies, J BIOL CHEM, 275(9), 2000, pp. 6375-6380
Authors:
Lijnen, HR
Arza, B
Van Hoef, B
Collen, D
Declerck, PJ
Citation: Hr. Lijnen et al., Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3), J BIOL CHEM, 275(48), 2000, pp. 37645-37650
Authors:
Kwaan, HC
Wang, J
Svoboda, K
Declerck, PJ
Citation: Hc. Kwaan et al., Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis, BR J CANC, 82(10), 2000, pp. 1702-1708
Authors:
Willems, PKA
Gils, A
Aertgeerts, K
De Ranter, CJ
Declerck, PJ
Citation: Pka. Willems et al., Induction of conformational changes within crystals of plasminogen activator inhibitor-1 (PAI-1), FIBRINOL PR, 13(4-5), 1999, pp. 203-207
Authors:
Willems, PKA
Rabijns, A
Aertgeerts, K
Vleugels, N
Knockaert, I
De Bondt, HL
De Ranter, CJ
Declerck, PJ
Citation: Pka. Willems et al., Plasminogen activator inhibitor 1 (PAI-1) in its active conformation: crystallization and preliminary X-ray diffraction data, ACT CRYST D, 55, 1999, pp. 574-576
Citation: Th. Ngo et Pj. Declerck, Immunological quantitation of rabbit plasminogen activator inhibitor-1 in biological samples - Evidence that rabbit platelets do not contain PAI-1, THROMB HAEM, 82(5), 1999, pp. 1510-1515
Authors:
Halleux, CM
Declerck, PJ
Tran, SL
Detry, R
Brichard, SM
Citation: Cm. Halleux et al., Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: Stimulation by glucocorticoids and inhibition by catecholamines, J CLIN END, 84(11), 1999, pp. 4097-4105
Authors:
Verhamme, I
Kvassman, JO
Day, D
Debrock, S
Vleugels, N
Declerck, PJ
Shore, JD
Citation: I. Verhamme et al., Accelerated conversion of human plasminogen activator inhibitor-1 to its latent form by antibody binding, J BIOL CHEM, 274(25), 1999, pp. 17511-17517